新冠开放药物研发的惊险历程。 - Suppr

A white-knuckle ride of open COVID drug discovery.

作者信息

von Delft Frank, Calmiano Mark, Chodera John, Griffen Ed, Lee Alpha, London Nir, Matviuk Tatiana, Perry Ben, Robinson Matt, von Delft Annette

出版信息

Nature. 2021 Jun;594(7863):330-332. doi: 10.1038/d41586-021-01571-1.

DOI:10.1038/d41586-021-01571-1

PMID:34127864

Abstract

摘要

相似文献

A white-knuckle ride of open COVID drug discovery.

Nature. 2021 Jun;594(7863):330-332. doi: 10.1038/d41586-021-01571-1.

Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease.

Signal Transduct Target Ther. 2021 May 29;6(1):212. doi: 10.1038/s41392-021-00628-x.

Are open-source approaches the most efficient way forward for COVID-19 drug discovery?

Expert Opin Drug Discov. 2021 Feb;16(2):115-117. doi: 10.1080/17460441.2020.1820983. Epub 2020 Sep 11.

Apigenin analogues as SARS-CoV-2 main protease inhibitors: screening approach.

Bioengineered. 2022 Feb;13(2):3350-3361. doi: 10.1080/21655979.2022.2027181.

Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.

Comb Chem High Throughput Screen. 2021;24(3):441-454. doi: 10.2174/1386207323999200730205447.

design of new chemical entities for SARS-CoV-2 using artificial intelligence.

Future Med Chem. 2021 Mar;13(6):575-585. doi: 10.4155/fmc-2020-0262. Epub 2021 Feb 16.

Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.

Molecules. 2021 Feb 4;26(4):797. doi: 10.3390/molecules26040797.

An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro.

Sci Rep. 2021 Nov 23;11(1):22796. doi: 10.1038/s41598-021-02266-3.

Protease inhibitors targeting the main protease and papain-like protease of coronaviruses.

Expert Opin Ther Pat. 2021 Apr;31(4):309-324. doi: 10.1080/13543776.2021.1857726. Epub 2020 Dec 12.

A call to arms.

Science. 2021 Mar 12;371(6534):1092-1095. doi: 10.1126/science.371.6534.1092. Epub 2021 Mar 11.

引用本文的文献

Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.

bioRxiv. 2025 Jun 17:2025.06.16.660018. doi: 10.1101/2025.06.16.660018.

High-throughput crystallographic fragment screening of Zika virus NS3 Helicase.

bioRxiv. 2024 Apr 29:2024.04.27.591279. doi: 10.1101/2024.04.27.591279.

On the origins of SARS-CoV-2 main protease inhibitors.

RSC Med Chem. 2023 Oct 13;15(1):81-118. doi: 10.1039/d3md00493g. eCollection 2024 Jan 25.

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

Science. 2023 Nov 10;382(6671):eabo7201. doi: 10.1126/science.abo7201.

A community effort in SARS-CoV-2 drug discovery.

Mol Inform. 2024 Jan;43(1):e202300262. doi: 10.1002/minf.202300262. Epub 2023 Nov 14.

Discovery of senolytics using machine learning.

Nat Commun. 2023 Jun 10;14(1):3445. doi: 10.1038/s41467-023-39120-1.

An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition.

Nat Commun. 2023 Mar 20;14(1):1545. doi: 10.1038/s41467-023-37035-5.

Development of artificial neural network models to predict the PAMPA effective permeability of new, orally administered drugs active against the coronavirus SARS-CoV-2.

Netw Model Anal Health Inform Bioinform. 2023;12(1):16. doi: 10.1007/s13721-023-00410-9. Epub 2023 Feb 6.

On drug discovery against infectious diseases and academic medicinal chemistry contributions.

Beilstein J Org Chem. 2022 Sep 29;18:1355-1378. doi: 10.3762/bjoc.18.141. eCollection 2022.

CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding.

Nat Rev Chem. 2022 Apr;6(4):287-295. doi: 10.1038/s41570-022-00363-z. Epub 2022 Feb 15.

本文引用的文献

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.

Nat Commun. 2020 Oct 7;11(1):5047. doi: 10.1038/s41467-020-18709-w.

Crowdsourcing drug discovery for pandemics.

Nat Chem. 2020 Jul;12(7):581. doi: 10.1038/s41557-020-0496-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A white-knuckle ride of open COVID drug discovery.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献